socalTECH

APRIL 24, 2012

Amgen Ventures , the venture capital arm of Thousand Oaks-based Amgen , has re-upped on an investment in a biopharmaceuticals developing microRNA-based treatments for cardiovascular and muscle disease. and Broadview Ventures. miRagen is based in Boulder, Colorado.

Thousand Oaks 150

Thousand Oaks Venture Capital Invest Capital 150

socalTECH

JANUARY 22, 2010

The latest numbers from the MoneyTree Report from PricewaterhouseCoopers and the National Venture Capital Association (NVCA), based on data from Thomson Reuters, were released this morning, finding that there was $587.8M invested in Southern California in Q4. was invested in the region. in investments.

Southern California 113

Southern California Invest Venture Capital Orange County 113

socalTECH

JANUARY 10, 2014

Thousand Oaks-based Atara Biotherapeutics announced this morning that it is in a second close of its Series B funding round, bringing its total raised in the funding to $52M. amgen lifescience disease renal capital venture biotherapeutics atara' READ MORE>>.

Thousand Oaks 147

Thousand Oaks Capital Funding Invest 147

socalTECH

JANUARY 9, 2017

Thousand Oaks-based Amgen is the lead investor in a round for San Francisco- and Bozeman, Montana-based SiteOne Therapeutics , SiteOne said on Friday. SiteOne said it raised $15M in a Series B funding round, which was led b Amgen, and also included Next Frontier Capital and insiders.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

JULY 30, 2018

Thousand Oaks-based Amgen has returned as one of the investors in cancer therapeutis developer Sutro Biopharma , as part of an $85.4M funding round. South San Francisco-based Sutro Biopharma said last week that it has raised $85.4M in a Series E funding round.

Thousand Oaks 100

Thousand Oaks Invest Capital Funding 100

socalTECH

APRIL 8, 2014

Thousand Oaks-based drug development company Atara Biotherapeutics announced this morning that it has added Matthew K. Fust as a board member, and hired Mitchall G. Clark as its Chief Regulatory and Quality Assurance Officer. READ MORE>>. atara biotherapeutics renal disease lifescience amgen executive board'

Thousand Oaks 138

Thousand Oaks Invest Capital Funding 138

socalTECH

JANUARY 4, 2019

Atara Biotherapeutics , the biopharmaceuticals firm which has its manufacturing and research efforts based in Thousand Oaks, said on Thursday that its current President and CEO, Isaac Ciechanover, M.D., The company is based in South San Francisco, but was founded in Thousand Oaks and has a large facility in the city.

Thousand Oaks 113

Thousand Oaks Research Invest Capital 113

socalTECH

NOVEMBER 17, 2017

Amgen Ventures , the venture investment arm of Thousand Oaks-based Amgen , is one of the new investors in precision oncology and medicine startup Syapse.

Thousand Oaks 113

Thousand Oaks Funding Software Capital 113

socalTECH

MARCH 8, 2016

Thousand Oaks-based Amgen has made another investment this morning in immunology startup Tizona Therapeutics , via its venture capital arm, Amgen Ventures. Series A investors--including Amgen Ventures--also participated, with investments from MPM Capital, Astellas Venture Management and InterWest Partners.

Thousand Oaks 100

Thousand Oaks Funding Venture Capital Invest 100

socalTECH

OCTOBER 23, 2015

Thousand Oaks-based SunBrite TV , a manufacturer of large screen, HDTV screens specifically designed to be installed outdoors, next to pools, on patios, and elsewhere, has been acquired by SnapAV , which is owned by private equity investor General Atlantic. SunBriteTV was backed by Bunker Hill Capital. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Screening Equity Acquisition 100

socalTECH

OCTOBER 12, 2016

Thousand Oaks-based Akriveia Therapeutics , a biotechnology startup focused on immuno-oncology, announced this morning that it has raised $7.5M in a Series A investment. The investment came from F-Prime Capital Partners.

Thousand Oaks 100

Thousand Oaks Research Activity Invest 100

socalTECH

OCTOBER 9, 2015

Thousand Oaks-based Amgen has seen an exit out of its startup investment portfolio, and activities of its Amgen Ventures venture capital arm, at Berkeley-based Adheron Therapeutics this morning. READ MORE>>.

Thousand Oaks 100

Thousand Oaks Venture Capital Activity Capital 100

socalTECH

JULY 6, 2015

Thousand Oaks-based Teledyne Technologies has increased its stake in San Diego-based Ocean Aero , a developer of unmanned, robotic underwater and surface vehicles used for the scientific, defense, and oil and gas market, the company said late Friday. Teledyne made its initial investment in Ocean Aero in July of 2014.

Thousand Oaks 100

Thousand Oaks San Diego Invest Marketing 100

socalTECH

DECEMBER 8, 2022

Thousand Oaks-based Dantari has raised $47M in its Series A funding, saying that it has launched a new, clinical-stage biotechnology company developing targeted therapeutics for the treatment of cancers and other diseases. Dantari has appointed Richard A. Markus, M.D., a co-founding managing director at Westlake.

Westlake Village 100

Westlake Village Thousand Oaks CalTech Funding 100

socalTECH

MAY 6, 2016

Thousand Oaks-based Amgen has helped to back a new, life sciences fund, managed by San Francisco-based venBio , as an anchor supporter of a new fund. venBio did not say how much Amgen committed to the fund, which is venBio's second life sciences fund.

Thousand Oaks 100

Thousand Oaks Funding Help Technology 100

socalTECH

OCTOBER 29, 2015

I grew up in Thousand Oaks, went to USC, and we met each other way back in the 90's. Where there are lots of players focused on different types of equity, different types of investments, different types of debt, they're doing it in a very unfocused manner. Brew Johnson: It's exciting to be building this business in LA.

Southern California 100

Southern California Google Technical Review Manhattan Beach 100

SoCal Delicious

APRIL 5, 2010

• Jack Gilbert , once the chief executive officer of a large Los Angeles-based corporation, later founded Thousand Oaks Land Development and played a major role in the development of Thousand Oaks area, leading that city’s emergence as a major business and corporate center.

Santa Barbara 53

Santa Barbara Thousand Oaks Oracle Ventura 53

Xconomy

JULY 22, 2016

It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. And in other Amgen news, the Thousand Oaks, CA, company filed for FDA approval of osteoporosis drug romosuzumab.

Startup 40

Startup San Diego News Thousand Oaks 40

socalTECH

JANUARY 5, 2017

the founding shareholder and chairman and treasurer of Thousand Oaks-based Amgen , has died, at the age of 90. Bowes--who also founded venture capital firm USVP --died peacefully in his home on December 28th. Bowes founded USVP after spending nearly 25 years at investment banking firm Blyth & Co., Bowes, Jr. ,

Thousand Oaks 113

Thousand Oaks Venture Capital Capital Invest 113